- Home
- CYN vs QNRX Comparison
CYN vs QNRX Comparison
Compare CYN & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYN
- QNRX
- Stock Information
- Founded
- CYN 2013
- QNRX 2018
- Country
- CYN United States
- QNRX United States
- Employees
- CYN N/A
- QNRX N/A
- Industry
- CYN EDP Services
- QNRX Medical/Dental Instruments
- Sector
- CYN Technology
- QNRX Health Care
- Exchange
- CYN Nasdaq
- QNRX Nasdaq
- Market Cap
- CYN N/A
- QNRX 3.3M
- IPO Year
- CYN 2021
- QNRX N/A
- Fundamental
- Price
- CYN $4.36
- QNRX $6.26
- Analyst Decision
- CYN
- QNRX
- Analyst Count
- CYN 0
- QNRX 0
- Target Price
- CYN N/A
- QNRX N/A
- AVG Volume (30 Days)
- CYN 47.5K
- QNRX 44.8K
- Earning Date
- CYN 05-07-2025
- QNRX 05-13-2025
- Dividend Yield
- CYN N/A
- QNRX N/A
- EPS Growth
- CYN N/A
- QNRX N/A
- EPS
- CYN N/A
- QNRX N/A
- Revenue
- CYN $409,777.00
- QNRX N/A
- Revenue This Year
- CYN $1,162.03
- QNRX N/A
- Revenue Next Year
- CYN $427.83
- QNRX N/A
- P/E Ratio
- CYN N/A
- QNRX N/A
- Revenue Growth
- CYN N/A
- QNRX N/A
- 52 Week Low
- CYN $3.62
- QNRX $5.01
- 52 Week High
- CYN $2,700.00
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- CYN 35.22
- QNRX 42.24
- Support Level
- CYN $5.05
- QNRX $6.05
- Resistance Level
- CYN $5.49
- QNRX $7.09
- Average True Range (ATR)
- CYN 0.41
- QNRX 0.74
- MACD
- CYN 0.46
- QNRX 0.15
- Stochastic Oscillator
- CYN 32.39
- QNRX 41.50
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.